British American Tobacco (BATS) Trading Update summary
Event summary combining transcript, slides, and related documents.
Trading Update summary
11 Jan, 20262024 performance and outlook
Performance is in line with expectations, with full-year guidance of low single-digit revenue and adjusted profit growth on an organic, constant currency basis.
Second-half acceleration is driven by new category innovation, U.S. commercial actions, and inventory normalization.
Improved new category revenue growth is expected in H2, with continued focus on profitability in heated products and modern oral.
Macro environment remains mixed, but early signs of recovery and easing interest rates are anticipated to benefit 2025.
Technical guidance updated for FX: 1.5% transactional and 4.5% translational headwinds on adjusted profit.
Combustibles and regional performance
U.S. combustibles face challenging macro conditions and illicit vapor proliferation, but premium segment volume share is up 50 bps year-to-date.
U.S. commercial actions in combustibles gaining traction, with volume share flat and value share down 30 bps; AME and APMEA regions show volume and value share gains.
Robust pricing and share gains in AME and APMEA, with strong contributions from Brazil, Mexico, Pakistan, Sri Lanka, and Turkey.
Outside the U.S., solid combustible performance continues, with supportive environments in Turkey, Brazil, Nigeria, and Japan.
Expecting improved revenue growth in both New Category and Combustibles segments in H2 versus H1.
New categories: vapor, heated, and modern oral
Maintains global vapor value share leadership at 40.3% in top markets; U.S. share at 50.7% but impacted by illicit products.
Innovations like Vuse Go 2.0, Vuse Go Reload, and upcoming Vuse Ultra target premium vapor segment.
Heated products see improved growth from glo Hyper Pro and new consumables, with premium positioning and recovery in Japan and Italy.
Modern oral (Velo) shows strong growth, especially in non-traditional markets like the U.K. and Poland, and U.S. share up 180 bps year-to-date.
Velo Plus national rollout underway in the U.S., targeting 110,000 outlets by Q1 2025.
Latest events from British American Tobacco
- Accelerating smokeless transformation and U.S. growth through innovation and regulatory action.BATS
Consumer Analyst Group of New York Conference (CAGNY) 202619 Feb 2026 - 2025 results hit top guidance, led by Modern Oral growth and strong U.S. and AME performance.BATS
H2 202512 Feb 2026 - New Category growth and innovation offset U.S. headwinds, supporting full-year guidance.BATS
H1 20243 Feb 2026 - Guidance reaffirmed as new categories and innovation drive H2 acceleration and cash returns.BATS
Trading Update31 Jan 2026 - Accelerating innovation and smokeless growth, with robust financials and U.S. market stabilization.BATS
21st Annual dbAccess Global Consumer Conference 202431 Jan 2026 - Accelerates smokeless transformation, targeting >50% revenue from new categories by 2035.BATS
CMD 202419 Jan 2026 - New category growth and cost discipline offset regulatory and illicit trade headwinds in 2024.BATS
H2 20248 Jan 2026 - FY25 outlook reaffirmed with growth, strong U.S. momentum, and a £1.3bn FY26 share buy-back.BATS
Trading Update9 Dec 2025 - FY25 outlook raised as U.S. and Modern Oral growth offset regulatory headwinds.BATS
Trading Update18 Nov 2025